Defining postsurgical neuropathic pain and exploring the potential role of the selective transient receptor potential vanilloid-1 (TRPV1) receptor agonist, high-concentration capsaicin (8%) topical system (HCCTS), in its treatment

Allen S, Carnevale AE, Marcondes L, Moore K

American Society of Pain & Neuroscience (ASPN) Conference

See event page
Link copied successfully!

The content includes information pertaining to products or uses that have not received approval from the US Food and Drug administration. Averitas Pharma does not recommend the use of its products outside the approved prescribing information. For full prescribing information, including indications, contraindications, warnings, precautions, and adverse events, please refer to the approved product labeling.

REF-45843

Related content

See all congress contributions

DPN, diabetic peripheral neuropathy; HCCTS, high-concentration capsaicin topical system.

N/A-US-01-25-0012 | July 2025